Tumor-stroma co-evolution in prostate cancer progression and metastasis

Area of Science:

• Oncology
• Cancer Biology
• Cellular Signaling

Background:

• Cancer progression involves complex interactions between cancer cells and the tumor microenvironment.
• Cancer cells co-evolve with stromal cells, acquiring adaptive survival mechanisms and mimicking other cell types (e.g., osteomimicry, vasculomimicry).
• Prostate cancer cells demonstrate osteomimetic properties, enabling survival and proliferation in the bone microenvironment.

Purpose of the Study:

• To investigate the co-evolution of cancer cells and their microenvironment.
• To understand the mechanisms of cancer cell mimicry, such as osteomimicry.
• To explore therapeutic strategies targeting cancer-stroma interactions.

Main Methods:

• Studied the genotypic and phenotypic changes of prostate cancer cells co-evolving with stroma.
• Investigated signaling interactions within the bone microenvironment, including reactive oxygen species and specific factors.
• Examined the acquisition of osteomimetic properties by cancer cells.

Main Results:

• Prostate cancer cells co-evolve with stroma, acquiring osteomimetic characteristics.
• Signaling pathways involving reactive oxygen species, beta2-microglobulin, and RANKL are implicated in bone metastasis.
• Cancer cells exhibit mimicry of other cell types, contributing to their survival and progression.

Conclusions:

• Targeting cancer-associated stromal microenvironment signaling pathways alongside conventional therapies may offer synergistic benefits.
• Understanding and co-targeting cancer and stromal interactions is crucial for improving cancer treatment outcomes.
• The co-evolution of cancer cells and their microenvironment drives adaptive changes essential for tumor progression and metastasis.